Apellis Pharmaceuticals, Inc.
做多

APLS ; target $40 pushed by 17% short interest

107
Short interest of 17% can push this out of the wedge formed. Pharma stocks will make a comeback closer we get to vaccine hypes again once the tech bubble pops

免责声明

这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。